Approval · Notice of Compliance 10797 · 2009
IMURAN: Notice of Compliance 10797
Issued November 24, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10797
- Date
- November 24, 2009
- Company
- Triton Pharma Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Immunosuppressive agent
Products in this notice
Medicinal ingredients
- AZATHIOPRINE 50 MG per TAB
- AZATHIOPRINE SODIUM 50 MG per VIAL